Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 15;9(1):e84833.
doi: 10.1371/journal.pone.0084833. eCollection 2014.

Atp6v1c1 may regulate filament actin arrangement in breast cancer cells

Ming Cai  1 , Pengcheng Liu  2 , Li Wei  1 , Jinshen Wang  1 , Jin Qi  1 , Shengmei Feng, Lianfu Deng
Affiliations

Atp6v1c1 may regulate filament actin arrangement in breast cancer cells

Ming Cai et al. PLoS One. .

Erratum in

  • PLoS One. 2014;9(1). doi:10.1371/annotation/ca9f2d5b-93ab-4d7c-b577-cd045b343e53

Abstract

Previous studies have shown that the rate of breast cancer metastasis correlates with the expression of vacuolar H(+)-ATPases (V-ATPases). However, how V-ATPase is involved in breast cancer metastasis remains unknown. Our previous study showed that Atp6v1c1-depleted osteoclasts did not form organized actin rings and that Atp6v1c1 co-localizes with F-actin. In this study, we found that the normal arrangement of filamentous actin is disrupted in Atp6v1c1-depleted 4T1 mouse breast cancer cells and in the ATP6V1C1-depleted human breast cancer cell lines MDA-MB-231 and MDA-MB-435s. We further found that Atp6v1c1 co-localizes with F-actin in 4T1 cells. The results of our study suggest that high expression of Atp6v1c1 affects the actin structure of cancer cells such that it facilitates breast cancer metastasis. The findings also indicate that Atp6v1c1 could be a novel target for breast cancer metastasis therapy.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Atp6v1c1 knockdown 4T1 cell clone selection and lack of expression of Atp6v1c2 in Atp6v1c1-depleted 4T1 cells.
(a) Atp6v1c1 expression in different 4T1 cells as indicated by western blotting. (b) RT-PCR assays of lung and different 4T1 cells as indicated were performed with gene-specific primers for Atp6v1c1, Atp6v1c2, and β-actin.
Figure 2
Figure 2. Regular F-actin arrangement was blocked in Atp6v1c1-depleted 4T1 cells.
F-actin Oregon Green® 514 phalloidin staining of different 4T1 cells as indicated. Nuclei were visualized with DAPI. The cells shown are representative of the data (n = 3).
Figure 3
Figure 3. Atp6v1c1 co-localized with F-actin in 4T1 cells.
Anti-Atp6v1c1 immunostaining and F-actin Oregon Green® 514 phalloidin staining of 4T1 cells. In the merged image, yellow staining showed that F-actin and Atp6v1c1 colocalized in the plasma and plasma membrane of 4T1 cells. The white arrows showed that most of the F-actin and Atp6v1c1 colocalization focused on the plasma membrane. The cells shown are representative of the data (n = 3).
Figure 4
Figure 4. Verification of shRNA targeting to human ATP6V1C1 in human breast cancer cell lines.
(a) ATP6V1C1 expression in different lentivirus-treated MDA-MB-231 cells as indicated by western blotting. (b) ATP6V1C1 expression in different lentivirus-treated MDA-MB-435s cells as indicated by western blotting.
Figure 5
Figure 5. Regular F-actin arrangement was blocked in ATP6V1C1-depleted MDA-MB-231 and MDA-MB-435s cells.
F-actin rhodamine phalloidin of different lentivirus-treated cells as indicated. The white arrows showed cells with disrupted actin cytoskeleton compared to control cells. The cells shown are representative of the data (n = 3).
See this image and copyright information in PMC

References

    1. Sennoune SR, Bakunts K, Martinez GM, Chua-Tuan JL, Kebir Y, et al. (2004) Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 286: C1443–C1452. - PubMed
    1. Martinez-Zaguilan R, Raghunand N, Lynch RM, Bellamy W, Martinez GM, et al. (1999) pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol 57: 1037–1046. - PubMed
    1. Xu J, Cheng T, Feng HT, Pavlos NJ, Zheng MH (2007) Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis. Histol Histopathol 22: 443–454. - PubMed
    1. Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–929. - PubMed
    1. Forgac M (1999) Structure and properties of the vacuolar (H+)-ATPases. J Biol Chem 274: 12951–12954. - PubMed

Publication types